Luminopia
Commercial- Indications
- Amblyopia
Company intelligence / Profile preview
Luminopia
Cambridge, Massachusetts, United Statesluminopia.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Commercial
01
Overview
Luminopia’s lead product has demonstrated safety and efficacy in three US-based clinical trials, including a pivotal Phase 3 trial showing significant improvement in vision after just twelve weeks of use. Real-world registry data confirm similar improvements and high adherence rates compared to traditional treatments like patching or atropine drops. The therapy was cleared by the FDA through the De Novo pathway in October 2021 and continues to show benefit across broader patient populations.
- Therapeutic areas
- Ophthalmology
- Modalities
- Non-pharmacological therapyDevice (VR-based digital therapeutic)Software-only digital therapeutic
- Industry
- Digital Health Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Boston Children’s Hospital (innovation partner/advisor/equity holder)
Beyond the preview
Go deeper on Luminopia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Luminopia.